Fred Eshelman, Angel Investor

Fred Eshelman is Chairman of Furiex Pharmaceuticals and Principal of Eshelman Ventures LLC, where he has focused on advancing pharmaceutical innovation and supporting emerging healthcare companies. Based in Wilmington, North Carolina, he brings decades of experience in drug development, commercialization, and strategic investment. His career reflects a strong emphasis on scaling biotech and pharmaceutical ventures, guiding companies through growth and market expansion. He has been a consistent supporter of innovation in life sciences and healthcare. As an angel investor, Fred has backed ventures in biotechnology and medicine. His recent investment was in Breakthru Medicine, a Series A company, highlighting his interest in startups developing transformative therapies and advancing medical innovation.